It’s a major step back from statements made at a White House news conference in September, when President Donald Trump and FDA commissioner Marty Makary announced the drug was under review to benefit patients with autism.
Related Posts
-
‘If I can’t have her, no one will’: Police say father caused 2022 Pennsylvania house explosion with kids inside
The man’s wife found notes that included an alleged admission, court documents say.
-
Iowa State announces six members of 2026 athletics Hall of Fame class
A jersey retirement ceremony for Georges Niang could be on the way in the coming…
-
Alabama governor commutes death sentence of man who didn’t fire fatal shot
Alabama Gov. Kay Ivey has commuted the death sentence of a 75-year-old inmate who was…
-
Bracketology: Iowa State eyes No. 2 seed; where will UNI play?
The state of Iowa is in line to send three teams to the NCAA Tournament…
Leave a Reply